In fact, the Italian Agency for Drug Administration allows the reimbursement of FSH replacement therapy only in men with idiopathic impaired spermatogenesis having confirmed serum FSH levels less than 8 IU/L (http://www.agenziafarmaco.gov.it/). Here, BRD2 is linked to Abnormal spermatogenesis.